Efthimios Dardiotis1, Vasileios Siokas1, Maria Sokratous1, Zisis Tsouris1, Athina-Maria Aloizou1, Desponia Florou1, Metaxia Dastamani1, Alexios-Fotios A Mentis1, Alexandros G Brotis1. 1. Department of Neurology (ED, VS, MS, ZT, A-MA, DF, MD), Laboratory of Neurogenetics, University of Thessaly, University Hospital of Larissa, Greece; Department of Microbiology (A-FAM), University of Thessaly, University Hospital of Larissa, Larissa, Greece; Public Health Laboratories (A-FAM), Hellenic Pasteur Institute, Athens, Greece; and Department of Neurosurgery (AGB), University of Thessaly, University Hospital of Larissa, Larissa, Greece.
Abstract
BACKGROUND: Several studies have examined the relationship between body mass index (BMI) and survival from amyotrophic lateral sclerosis (ALS). Many indicate that low BMI at diagnosis or during follow-up may be associated with accelerated progression and shortened survival. This study systematically evaluated the relationship between BMI and survival in patients with ALS. METHODS: The PubMed database was searched to identify all available studies reporting time-to-event data. Eight studies with 6,098 patients fulfilled the eligibility criteria. BMI was considered a continuous and ordered variable. Interstudy heterogeneity was assessed by the Cochran Q test and quantified by the I2 metric. Fixed- or random-effects odds ratios summarized pooled effects after taking interstudy variability into account. Significance was set at p < 0.05. RESULTS: The ALS survival hazard ratio (HR) decreased approximately by 3% (95% confidence interval [CI]: 2%-5%) for each additional BMI unit when BMI was considered a continuous variable. When BMI was considered a categorical variable, the HRs for "normal" BMI vs "overweight" BMI and "obese" BMI were estimated to be as high as 0.91 (95% CI: 0.79-1.04) and 0.78 (95% CI: 0.60-1.01), respectively. The HR for the comparison of the "normal" BMI vs "underweight" BMI was estimated to be as high as 1.94 (95% CI: 1.42-2.65). CONCLUSIONS: BMI is significantly and inversely associated with ALS survival.
BACKGROUND: Several studies have examined the relationship between body mass index (BMI) and survival from amyotrophic lateral sclerosis (ALS). Many indicate that low BMI at diagnosis or during follow-up may be associated with accelerated progression and shortened survival. This study systematically evaluated the relationship between BMI and survival in patients with ALS. METHODS: The PubMed database was searched to identify all available studies reporting time-to-event data. Eight studies with 6,098 patients fulfilled the eligibility criteria. BMI was considered a continuous and ordered variable. Interstudy heterogeneity was assessed by the Cochran Q test and quantified by the I2 metric. Fixed- or random-effects odds ratios summarized pooled effects after taking interstudy variability into account. Significance was set at p < 0.05. RESULTS: The ALS survival hazard ratio (HR) decreased approximately by 3% (95% confidence interval [CI]: 2%-5%) for each additional BMI unit when BMI was considered a continuous variable. When BMI was considered a categorical variable, the HRs for "normal" BMI vs "overweight" BMI and "obese" BMI were estimated to be as high as 0.91 (95% CI: 0.79-1.04) and 0.78 (95% CI: 0.60-1.01), respectively. The HR for the comparison of the "normal" BMI vs "underweight" BMI was estimated to be as high as 1.94 (95% CI: 1.42-2.65). CONCLUSIONS: BMI is significantly and inversely associated with ALS survival.
Authors: Ali Jawaid; Santosh B Murthy; Andrew M Wilson; Salah U Qureshi; Moath J Amro; Michael Wheaton; Ericka Simpson; Yadollah Harati; Adriana M Strutt; Michele K York; Paul E Schulz Journal: Amyotroph Lateral Scler Date: 2010-05-26
Authors: Erik von Elm; Douglas G Altman; Matthias Egger; Stuart J Pocock; Peter C Gøtzsche; Jan P Vandenbroucke Journal: J Clin Epidemiol Date: 2008-04 Impact factor: 6.437
Authors: Alessandro Liberati; Douglas G Altman; Jennifer Tetzlaff; Cynthia Mulrow; Peter C Gøtzsche; John P A Ioannidis; Mike Clarke; P J Devereaux; Jos Kleijnen; David Moher Journal: BMJ Date: 2009-07-21
Authors: Stuart J McCarter; Elizabeth A Coon; Rodolfo Savica; Erik K St Louis; James H Bower; Eduardo E Benarroch; Paola Sandroni; Phillip Low; Wolfgang Singer Journal: Mov Disord Date: 2020-04-22 Impact factor: 10.338
Authors: Stephen A Goutman; Jonathan Boss; Kai Guo; Fadhl M Alakwaa; Adam Patterson; Sehee Kim; Masha Georges Savelieff; Junguk Hur; Eva L Feldman Journal: J Neurol Neurosurg Psychiatry Date: 2020-09-14 Impact factor: 13.654
Authors: Jeffrey T Ehmsen; Riki Kawaguchi; Damlanur Kaval; Anna E Johnson; Daniel Nachun; Giovanni Coppola; Ahmet Höke Journal: JCI Insight Date: 2021-07-08